Item Details

Print View

Exclusive Agreements Between Federal Agencies and Bristol-Myers Squibb Co. For Drug Development: Is the Public Interest Protected? : Hearing Before the Subcommittee on Regulation, Business Opportunities, and Energy of the Committee on Small Business, House of Representatives, One Hundred Second Congress, First Session, Washington, DC, July 29, 1991

United States. Congress. House. Committee on Small Business. Subcommittee on Regulation, Business Opportunities, and Energy
Format
Book; Government Document
Published
Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, 1992.
Language
English
ISBN
0160374928
SuDoc Number
Y 4.Sm 1:102-35
Description
iv, 503 p. : ill. ; 24 cm.
Notes
  • "Serial no. 102-35."
  • Includes bibliographical references.
Technical Details
  • Access in Virgo Classic
  • Staff View

    LEADER 01646cam a2200373Ia 4500
    001 u3402853
    003 SIRSI
    008 920310s1992 dcua b f000 0 eng d
    020
      
      
    a| 0160374928
    035
      
      
    a| (Sirsi) b2667563
    035
      
      
    a| b2667563
    035
      
      
    a| (OCoLC)25422083
    040
      
      
    a| FTC c| FTC d| GPO
    043
      
      
    a| n-us---
    049
      
      
    a| VALL
    074
      
      
    a| 1031-A, 1031-B (MF)
    086
    0
      
    a| Y 4.Sm 1:102-35
    110
    1
      
    a| United States. b| Congress. b| House. b| Committee on Small Business. b| Subcommittee on Regulation, Business Opportunities, and Energy.
    245
    1
    0
    a| Exclusive agreements between Federal agencies and Bristol-Myers Squibb Co. for drug development : b| is the public interest protected? : hearing before the Subcommittee on Regulation, Business Opportunities, and Energy of the Committee on Small Business, House of Representatives, One Hundred Second Congress, first session, Washington, DC, July 29, 1991.
    260
      
      
    a| Washington : b| U.S. G.P.O. : b| For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, c| 1992.
    300
      
      
    a| iv, 503 p. : b| ill. ; c| 24 cm.
    500
      
      
    a| "Serial no. 102-35."
    504
      
      
    a| Includes bibliographical references.
    596
      
      
    a| 17
    610
    2
    0
    a| Bristol-Myers Squibb Company.
    650
      
    0
    a| Drugs x| Research z| United States.
    650
      
    0
    a| Cancer x| Treatment x| Research z| United States.
    650
      
    0
    a| Exclusive contracts z| United States.
    941
      
      
    a| 04-29-92 b| 06-14-96 c| 3
    948
      
      
    a| 04/29/92 b| 06/14/96 c| 04/29/92
    999
      
      
    a| Y 4.Sm 1:102-35 w| SUDOC i| 35007000248983 l| LAW2-DOCS m| LAW t| DOCUMENT
▾See more
▴See less

Availability

Google Preview

Google Books Preview
Library Location Map Availability Call Number
Law 2nd Floor Documents Map Available